Companies
Chanelle Pharma profits fall more than 40 per cent ahead of Exponent deal
Sale volumes had increased 5 per cent but profits dropped as rising interest rates hit the holding company’s bottom line
Sale volumes had increased 5 per cent but profits dropped as rising interest rates hit the holding company’s bottom line
